Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
60.8M
-
Number of holders
-
172
-
Total shares
-
61.9M
-
Shares change
-
+3.59M
-
Total reported value, excl. options
-
$7.27B
-
Value change
-
+$416M
-
Put/Call ratio
-
0.66
-
Number of buys
-
87
-
Number of sells
-
-77
-
Price
-
$117.36
Significant Holders of Ascendis Pharma A/S - American Depositary Shares (ASND) as of Q1 2022
182 filings reported holding ASND - Ascendis Pharma A/S - American Depositary Shares as of Q1 2022.
Ascendis Pharma A/S - American Depositary Shares (ASND) has 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.9M shares
.
Largest 10 shareholders include Artisan Partners Limited Partnership (8.21M shares), RA CAPITAL MANAGEMENT, L.P. (7.57M shares), FMR LLC (5.35M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.87M shares), WELLINGTON MANAGEMENT GROUP LLP (4.67M shares), BAKER BROS. ADVISORS LP (4.54M shares), JANUS HENDERSON GROUP PLC (3.42M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2.64M shares), Avoro Capital Advisors LLC (2.2M shares), and GOLDMAN SACHS GROUP INC (1.75M shares).
This table shows the top 172 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.